H. Con. Res. 22
116th Congress
House
Exposing Congressional Drug Abuse Act
Official title: Requiring Members of the House of Representatives and the Senate to participate in random drug testing.
Congress
Congressional operations and organizationDrug trafficking and controlled substancesDrug, alcohol, tobacco useGovernment employee pay, benefits, personnel management
More subjectsShow fewer subjects
Government ethics and transparency, public corruptionGovernment information and archivesLegislative rules and procedureMembers of Congress
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Feb 27, 2019
Referred to the House Committee on House Administration.
Feb 27, 2019
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the House Committee on House Administration.
Plain-English summary
Exposing Congressional Drug Abuse Act
This concurrent resolution requires each Member of Congress, including a Delegate or Resident Commissioner, to submit to random tests for illegal use of controlled substances.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). H. Con. Res. 22: Exposing Congressional Drug Abuse Act. 116th Congress. Open America. https://openamerica.io/bill/116-HCONRES-22/
"H. Con. Res. 22: Exposing Congressional Drug Abuse Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HCONRES-22/.
H. Con. Res. 22, 116th Cong. (2026), https://openamerica.io/bill/116-HCONRES-22/.
[H. Con. Res. 22: Exposing Congressional Drug Abuse Act](https://openamerica.io/bill/116-HCONRES-22/)